Public announcement
The “Guarantors of EQIPD” officially announced their launch with a public press release. The society is registered since December 2021 and became fully operational now.
The “Guarantors of EQIPD” officially announced their launch with a public press release. The society is registered since December 2021 and became fully operational now.
Our book on quality in preclinical research, including many articles from authors within the EQIPD consortium, has just been published: Bespalov A, Michel MC, Steckler T (eds) Handbook of Experimental Pharmacology – Good Research Practice in Non-Clinical Pharmacology and Biomedicine, Springer Open, Cham, Switzerland. ISBN 978-3-030-33655-4, eBook ISBN 978-3-030-33656-1 (2020). Access the book HERE.
EQIPD and our efforts to ” Unclog pipeline for new medicines” is mentioned in form of a brief article in NATURE CORRESPONDENCE. Click here to get to the article!
The EQIPD Quality System is the result of a collaborative effort between several people and organizations, yet cannot specifically address all potential scenarios under which research rigor measures are needed and will be implemented. The foundation laid by EQIPD is formulated in the “core requirements” (see link below) and we welcome further efforts to support…
In the newest edition of the newsletter, find out more about the highlights of the EQIPD General Assembly meeting, the new project collaborations, CAMARADES winning the BNA’s ‘Credibility Prize’ and details on the 34th ECNP congress. Read the Newsletter here.
Hot of the press and we are excited: The EQIPD framework for rigor in the design, conduct, analysis, and documentation of animal experiments. It defines the demands for five domains researchers should be aware of and the needs for them in research design and publications.
The need for quality standards in preclinical research is gaining attention, especially in translational research. The IMI-PainCare consortium has reached out to EQIPD to collaborate in assessing the study design and data analysis for their studies in the BioPain and TRiPP groups. This collaboration will ensure equivalent quality standards in preclinical research among their project…